{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:36:25Z","timestamp":1791275785162,"version":"4.1.0"},"reference-count":35,"publisher":"BMJ","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1993,8]]},"abstract":"<jats:p>Myelosuppression is an important and potentially lethal complication of azathioprine treatment. The blood count has been reviewed in all patients treated with azathioprine for inflammatory bowel disease over 27 years in one hospital. Altogether 739 patients (422 with Crohn's disease, 284 with ulcerative colitis, and 33 with indeterminate colitis) were treated with 2 mg\/kg\/day azathioprine for a median of 12.5 months (range 0.5-132) between 1964 and 1991. Full blood counts were performed monthly for the duration of treatment. In 37 patients (5%) who developed bone marrow toxicity, the drug was withdrawn or the dose reduced. Thirty two of these patients were asymptomatic and five developed symptoms. Leucopenia (white blood count less than 3.0 x 10g\/l) occurred in 28 (3.8%) patients, in nine of whom it was severe (white blood count &lt; 2.0 x 10(9)\/l). Of these nine patients, three were pancytopenic: two died from sepsis and the other had pneumonia but recovered. A further two patients with severe leucopenia developed a mild upper respiratory infection only. Thrombocytopenia (platelet count &lt; 100,000 x 10(6)\/l) in 15 patients was associated with leucopenia in six and developed in isolation in a further nine (total 2%). Isolated thrombocytopenia was never clinically severe. Myelotoxicity from azathioprine developed at any time during drug treatment (range 2 weeks-11 years after starting the drug) and occurred either suddenly or over several months. Bone marrow suppression as a result of azathioprine treatment is uncommon when a moderate dose is used, but is potentially severe. Leucopenia is the commonest and most important haematological complication. Regular monitoring of the full blood count is recommended during treatment.<\/jats:p>","DOI":"10.1136\/gut.34.8.1081","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"1081-1085","source":"Crossref","is-referenced-by-count":422,"title":["Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience."],"prefix":"10.1136","volume":"34","author":[{"given":"W R","family":"Connell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Kamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J K","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J E","family":"Lennard-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[1993,8,1]]},"reference":[{"key":"ref_1","first-page":"1273","article-title":"Controlled trial of azathioprine in Crohn's disease","volume":"2","author":"Rhodes, J.; Bainton, D.; Beck, P.; Campbell, H.","year":"1971","unstructured":"Rhodes J, Bainton D, Beck P, Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 1273-76.","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0016-5085(74)80166-6","article-title":"Treatment ofCrohn's disease with azathioprine: a controlled evaluation","volume":"66","author":"Klein, M.; Binder, H.J.; Mitchell, M.; Aaronson, R.; Spiro, H.","year":"1974","unstructured":"Klein M, Binder HJ, Mitchell M, Aaronson R, Spiro H. Treatment ofCrohn's disease with azathioprine: a controlled evaluation. Gastroenterology 1974; 66: 916-22.","journal-title":"Gastroenterology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0016-5085(79)90385-8","article-title":"The national cooperative Crohn's disease study: results ofdrug treatment","volume":"77","author":"true","year":"1979","unstructured":"Summers RW, Switz DM, Sessions Jr JT et al. The national cooperative Crohn's disease study: results ofdrug treatment. Gastroenterology 1979; 77: 847-69.","journal-title":"Gastroenterology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.4.5945.627","article-title":"Azathioprine in ulcerative colitis: final report on controlled therapeutic trial","volume":"4","author":"Jewell, D.P.; Truelove, S.C.","year":"1974","unstructured":"Jewell DP, Truelove SC. Azathioprine in ulcerative colitis: final report on controlled therapeutic trial. BMJ 1974; 4: 627-30.","journal-title":"BMJ"},{"key":"ref_5","first-page":"944","article-title":"Controlled trial of azathioprine in Crohn's disease","volume":"2","author":"Willoughby, J.M.T.; Kumar, P.J.; Beckett, J.; Dawson, A.M.","year":"1971","unstructured":"Willoughby JMT, Kumar PJ, Beckett J, Dawson AM. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; 2: 944-6.","journal-title":"Lancet"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/bmj.284.6325.1291","article-title":"Controlled trial of azathioprine in ulcerative colitis","volume":"284","author":"Kirk, A.P.; Lennard-Jones, J.E.","year":"1982","unstructured":"Kirk AP, Lennard-Jones JE. Controlled trial of azathioprine in ulcerative colitis. BMJr 1982; 284: 1291-2.","journal-title":"BMJr"},{"key":"ref_7","first-page":"96","article-title":"A controlled trial of azathioprine in Crohn's diseaseA","volume":"69","author":"Rosenberg, J.L.; Levin, B.; Wall, A.J.; Kirsner, JR","year":"1975","unstructured":"Rosenberg JL, Levin B, Wall AJ, Kirsner JR. A controlled trial of azathioprine in Crohn's diseaseA. mJ-Dig Dis 1975; 8 Rosenberg JL, Wall AJ, Levin B, Binder HJ, Kirsner JB. A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gasn'oenrerology 1975; 69: 96-9.","journal-title":"mJ-Dig Dis; A controlled trial of azathioprine in the management of chronic ulcerative colitis"},{"key":"ref_8","first-page":"955","article-title":"Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease","volume":"2","author":"O'Donoghue, D.P.; Dawson, A.M.; Powell-Tuck, J.; Bown, R.L.; Lennard-Jones, J.E.","year":"1978","unstructured":"O'Donoghue DP, Dawson AM, Powell-Tuck J, Bown RL, Lennard-Jones JE. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet 1978; 2: 955-7.","journal-title":"Lancet"},{"key":"ref_9","first-page":"262","article-title":"Imuran in the treatment of ulcerative colitis","volume":"76","author":"Theodor, E.; Niv, Y.; Bat, L.","year":"1981","unstructured":"Theodor E, Niv Y, Bat L. Imuran in the treatment of ulcerative colitis. AmJ Gastroenterol 1981; 76: 262-6.","journal-title":"AmJ Gastroenterol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3109\/00365528509089276","article-title":"Long-term immunosuppressive treatment in Crohn's disease","volume":"20","author":"Nyman, M.; Hansson, I.; Eriksson, S.","year":"1985","unstructured":"Nyman M, Hansson I, Eriksson S. Long-term immunosuppressive treatment in Crohn's disease. Scand J Gastroenterol 1985; 20: 1197-203.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"ref_11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/00004836-198712000-00009","article-title":"Immunosuppressant treatment of inflammatory bowel disease. Pharmacological and clinical aspects","volume":"9","author":"Goldstein, F.","year":"1987","unstructured":"Goldstein F. Immunosuppressant treatment of inflammatory bowel disease. Pharmacological and clinical aspects. J Clin Gastroenterol 1987; 9(6): 654-8.","journal-title":"J Clin Gastroenterol"},{"key":"ref_12","first-page":"359","article-title":"Efficacy of 6mercaptopurine in refractory ulcerative colitis","author":"Present, D.H.; Chapman, M.L.; Rubin, P.H.","year":"1988","unstructured":"Present DH, Chapman ML, Rubin PH. Efficacy of 6mercaptopurine in refractory ulcerative colitis. Gastroenterology 1988; 94 (2): A359.","journal-title":"Gastroenterology"},{"key":"ref_13","first-page":"334","article-title":"The role of azathioprine in the management of ulcerative colitis","volume":"33","author":"Lobo, A.J.; Foster, P.N.; Burke, D.A.; Johnston, D.; Axon, A.T.R.","year":"1990","unstructured":"Lobo AJ, Foster PN, Burke DA, Johnston D, Axon ATR. The role of azathioprine in the management of ulcerative colitis. Dis Colon Rectum 1990; 33: 334-7.","journal-title":"Dis Colon Rectum"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0016-5085(91)90457-V","article-title":"Use of azathioprine of 6mercaptopurine in the treatment of Crohn's disease","volume":"101","author":"O'Brien, J.J.; Bayless, T.M.; Bayless, J.A.","year":"1991","unstructured":"O'Brien JJ, Bayless TM, Bayless JA. Use of azathioprine of 6mercaptopurine in the treatment of Crohn's disease. Gastroenterology 1991; 101: 39-46.","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-111-8-641","article-title":"6-Mercaptopurine in the management of inflammatory bowel disease: shortand long-term toxicity","volume":"111","author":"Present, D.H.; Meltzer, S.J.; Krumholz, M.P.; Wolke, A.; Korelitz, B.I.","year":"1989","unstructured":"Present DH, Meltzer SJ, Krumholz MP, Wolke A, Korelitz BI. 6-Mercaptopurine in the management of inflammatory bowel disease: shortand long-term toxicity. Ann Intern Med 1989; 111:641-9.","journal-title":"Ann Intern Med"},{"issue":"1","key":"ref_16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/0002-9343(85)90245-1","article-title":"Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment","volume":"78","author":"Kinlen, L.J.","year":"1985","unstructured":"Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78(1A): 44-49.","journal-title":"Am J Med"},{"key":"ref_17","first-page":"161","article-title":"Adverse effects of azathioprine","volume":"3","author":"Lawson, D.H.; Lovatt, G.E.; Gurton, C.S.; Hennings, R.C.","year":"1984","unstructured":"Lawson DH, Lovatt GE, Gurton CS, Hennings RC. Adverse effects of azathioprine. Advances in DrugReactions and Acute Poisoning Revue 1984; 3: 161-71.","journal-title":"Advances in DrugReactions and Acute Poisoning Revue"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1136\/ard.47.6.503","article-title":"Pancytopaenia related to azathioprine in rheumatoid arthritis","volume":"47","author":"Jeurissen, M.E.C.; AMTh, Boerbooms; Van de Putte, L.B.A.","year":"1988","unstructured":"Jeurissen MEC, Boerbooms AMTh, Van de Putte LBA. Pancytopaenia related to azathioprine in rheumatoid arthritis. Ann Rheum Dis 1988; 47: 503-5.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"ref_19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/00004836-198906000-00017","article-title":"Ulcerative colitis: prolonged remission following azathioprine induced pancytopaenia","volume":"11","author":"Burke, D.A.; Dixon, M.F.; Axon, A.T.R.","year":"1989","unstructured":"Burke DA, Dixon MF, Axon ATR. Ulcerative colitis: prolonged remission following azathioprine induced pancytopaenia. J Clin Gastroenterol 1989; 11(3): 327-30.","journal-title":"J Clin Gastroenterol"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/clpt.1989.119","article-title":"Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism","volume":"46","author":"Lennard, L.; Van Loon, J.A.; Weinshilboum, R.M.","year":"1989","unstructured":"Lennard L, Van Loon JA, Weinshilboum RM. Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism. Clin Pharmacol Ther 1989; 46: 149-54.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_21","first-page":"551","article-title":"Maintenance treatment for Crohn's disease: has the time arrived?","volume":"87","author":"Goldstein, F.","year":"1992","unstructured":"Goldstein F. Maintenance treatment for Crohn's disease: has the time arrived? AmJ Gastroenterol 1992; 87: 551-6.","journal-title":"AmJ Gastroenterol"},{"issue":"1&2","key":"ref_22","first-page":"157","article-title":"The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine","volume":"16","author":"KG, Van Scoik; CA, Johnson; WR, Porter","year":"1985","unstructured":"Van Scoik KG, Johnson CA, Porter WR. The pharmacology and metabolism of the thiopurine drugs 6-mercaptopurine and azathioprine. Drug Metabolism Reviews 1985; 16(1&2): 157-74.","journal-title":"Drug Metabolism Reviews"},{"issue":"94","key":"ref_23","first-page":"2268","article-title":"Knockenmarksschadigung bei immunsuppressiver therapie der juvenilen rheumatoiden arthritis und des Stillsyndroms mit azathioprin","volume":"1969","author":"Kolle, G.","unstructured":"Kolle G. Knockenmarksschadigung bei immunsuppressiver therapie der juvenilen rheumatoiden arthritis und des Stillsyndroms mit azathioprin. Dtsch Med Wochenschr 1969; 94: 2268-73.","journal-title":"Dtsch Med Wochenschr"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/ard.41.Suppl_1.44","article-title":"Rheumatoid arthritis: treatment with azathioprine [Imuran (R)]. Clinical side-effects and laboratory abnormalities","volume":"41","author":"Whisnant, J.K.; Pelkey, J.","year":"1982","unstructured":"Whisnant JK, Pelkey J. Rheumatoid arthritis: treatment with azathioprine [Imuran (R)]. Clinical side-effects and laboratory abnormalities. Ann Rheum Dis 1982; 41 (suppl): 44-47.","journal-title":"Ann Rheum Dis"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/0016-5085(79)90386-X","article-title":"National cooperative Crohn's disease study: adverse reactions to study drugs","volume":"77","author":"Singleton, J.W.; Law, D.H.; Kelley, M.L.; Mekhjian, H.S.; Sturdevant, R.A.L.","year":"1979","unstructured":"Singleton JW, Law DH, Kelley ML, Mekhjian HS, Sturdevant RAL. National cooperative Crohn's disease study: adverse reactions to study drugs. Gastroenterology 1979; 77: 870-82.","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00007890-197411000-00009","article-title":"Observation on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation","volume":"18","author":"Wickramasinghe, S.N.; Dodsworth, H.; Rault, R.M.J.; Hulme, B.","year":"1974","unstructured":"Wickramasinghe SN, Dodsworth H, Rault RMJ, Hulme B. Observation on the incidence and cause of macrocytosis in patients on azathioprine therapy following renal transplantation. Transplantation 1974; 18: 443-6.","journal-title":"Transplantation"},{"key":"ref_27","first-page":"57","article-title":"Erythroid toxicity of azathioprine","volume":"173","author":"McGrath, B.P.; Ibels, L.S.; Raik, E.; Hargave, M.; Mahony, J.F.; Stewart, J.H.","year":"1975","unstructured":"McGrath BP, Ibels LS, Raik E, Hargave M, Mahony JF, Stewart JH. Erythroid toxicity of azathioprine. Q Jf Med 1975; 173: 57-63.","journal-title":"Q Jf Med"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1001\/jama.1978.03290060054014","article-title":"San Antonio RP. Azathioprine-induced pure red blood cell aplasia","volume":"240","author":"Old, C.W.; Flannery, E.P.; Grogan, T.M.; Stone, W.H.","year":"1978","unstructured":"Old CW, Flannery EP, Grogan TM, Stone WH, San Antonio RP. Azathioprine-induced pure red blood cell aplasia. JAMA 1978; 240: 552-4.","journal-title":"JAMA"},{"key":"ref_29","first-page":"161","article-title":"Disease modifying drugs for progressive rheumatoid arthritis","volume-title":"Series on pharmacology in practice. Mayo Clin Proc 1980; 55","author":"Bunch, T.W.; O'Duffy, D.M.","unstructured":"Bunch TW, O'Duffy DM. Disease modifying drugs for progressive rheumatoid arthritis. Series on pharmacology in practice. Mayo Clin Proc 1980; 55: 161-79."},{"key":"ref_30","first-page":"223","article-title":"Azathioprineinduced pancytopaenia. Occurrence in two patients with connective-tissue diseases","volume":"141","author":"Bacon, B.R.; Treuhaft, W.H.; Goodman, A.M.","year":"1981","unstructured":"Bacon BR, Treuhaft WH, Goodman AM. Azathioprineinduced pancytopaenia. Occurrence in two patients with connective-tissue diseases. Arch IntMed 1981; 141: 223-6.","journal-title":"Arch IntMed"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1136\/bmj.1.5500.1418-a","article-title":"Dangers of immunosuppressive drugs in ulcerative colitis","volume":"1","author":"F, Avery Jones; JE, Lennard-Jones; JM, Hinton; WG, Reeves","year":"1966","unstructured":"Avery Jones F, Lennard-Jones JE, Hinton JM, Reeves WG. Dangers of immunosuppressive drugs in ulcerative colitis. BMJ 1966; 1: 1418.","journal-title":"BMJ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1365-2125.1983.tb02178.x","article-title":"Childhood leukemia: a relationship between intracellular 6mercaptopurine metabolites and neutropenia","volume":"16","author":"Lennard, L.; Rees, C.A.; Lilleyman, J.S.; Maddocks, J.L.","year":"1983","unstructured":"Lennard L, Rees, CA, Lilleyman JS, Maddocks JL. Childhood leukemia: a relationship between intracellular 6mercaptopurine metabolites and neutropenia. Br J Clin Pharmacol 1983; 16: 359-63.","journal-title":"Br J Clin Pharmacol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0022-3476(05)83063-X","article-title":"Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferasedeficient child with acute lymphocytic leukemia","volume":"119","author":"Evans, W.E.; Homer, M.; Chu, Y.Q.; Kalwinsky, D.; Roberts, W.M.","year":"1991","unstructured":"Evans WE, Homer M, Chu YQ, Kalwinsky D, Roberts WM, Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferasedeficient child with acute lymphocytic leukemia. J Paediatr 1991; 119:985-9.","journal-title":"J Paediatr"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-199205000-00016","article-title":"The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients","volume":"53","author":"Chochair, P.R.; Duley, J.A.; Simmonds, H.A.; Cameron, J.S.","year":"1992","unstructured":"Chochair PR, Duley JA, Simmonds HA, Cameron JS. The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 1992; 53: 1051-6.","journal-title":"Transplantation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/BF00483962","article-title":"Thiopurine methyltransferase biochemical genetics human lymphocyte activity","volume":"20","author":"J, Van Loon; RM, Weinshilboum","year":"1982","unstructured":"Van Loon J, Weinshilboum RM. Thiopurine methyltransferase biochemical genetics human lymphocyte activity. Biochem Genet 1982; 20: 637-58.","journal-title":"Biochem Genet"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.34.8.1081","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T08:41:24Z","timestamp":1765010484000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.34.8.1081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1993,8]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[1993,8,1]]},"published-print":{"date-parts":[[1993,8]]}},"alternative-id":["10.1136\/gut.34.8.1081"],"URL":"https:\/\/doi.org\/10.1136\/gut.34.8.1081","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"value":"0017-5749","type":"print"},{"value":"1468-3288","type":"electronic"}],"subject":[],"published":{"date-parts":[[1993,8]]}}}